Omega 7: Reduce Plaque Buildup & Triglycerides

Inspired by groundbreaking research from the National Institutes of Health (NIH), a recent study published in Molecular Nutrition & Food Research has shed new light on the role of omega-7 fatty acids in heart health. The research findings suggest a notable impact: omega-7 has been associated with a significant reduction in atherosclerotic lesions—by up to 45%—and a decrease in triglyceride levels of around 30%. These insights represent a leap forward in cardiovascular health management and suggest potential benefits of omega-7 supplementation.

The NIH team conducted a thorough investigation into the effects of omega-7, observing not just a slowing in the progression of atherosclerosis, but also improvements in lipid and glucose metabolism. Additionally, the study indicates that omega-7 may help reduce the expression of inflammation-related genes, highlighting its potential role in addressing cardiometabolic risks.

Puredia's CardiOmegia™ is designed to deliver omega-7 in its most natural triglyceride (TG) form. This approach ensures that we offer a product with exceptional purity and potency, setting a new benchmark in the supplement market. Understanding the diverse needs of our customers, we have developed CardiOmegia™ to be available in multiple formats:

  • A cold-water-soluble powder, perfect for easy integration into various product formulations.

  • A high-concentration free fatty acid powder that is tailored for optimal absorption and efficacy. With an 80% oil content, the recommended daily intake of CardiOmegia™ is conveniently low, at just 612.5mg.


Highest Omega 7 in Natural Triglyceride

100% Plant-based
100% Wholefood
TRICAP™ Microencapsulation Tech
Water Soluble
Sustainably & Responsibly Made

Learn More

This ingredient is certified with:


Reference
Yang, Z. et al. (2019) ‘Dietary palmitoleic acid attenuates atherosclerosis progression and hyperlipidemia in low‐density lipoprotein receptor‐deficient mice’, Molecular Nutrition & Food Research, 63(12). doi:10.1002/mnfr.201900120.